Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Progyny, Inc. Director's Dealing 2021

Nov 10, 2021

31752_dirs_2021-11-09_983451df-b9cf-4010-9a61-ab80accd0534.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Progyny, Inc. (PGNY)
CIK: 0001551306
Period of Report: 2021-11-05

Reporting Person: Bealer Jennifer (EVP, General Counsel)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-11-05 Common Stock S 5041 $64.657 Disposed 66590 Direct
2021-11-05 Common Stock S 1700 $65.104 Disposed 64890 Direct
2021-11-05 Common Stock S 2157 $66.277 Disposed 62733 Direct
2021-11-05 Common Stock S 981 $67.094 Disposed 61752 Direct
2021-11-05 Common Stock S 211 $68.058 Disposed 61541 Direct
2021-11-08 Common Stock A 30000 Acquired 91541 Direct
2021-11-08 Common Stock S 3463 $64.605 Disposed 88078 Direct
2021-11-08 Common Stock S 11499 $65.660 Disposed 76579 Direct
2021-11-08 Common Stock S 6963 $66.554 Disposed 69616 Direct
2021-11-08 Common Stock S 200 $67.165 Disposed 69416 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-11-08 Employee Stock Option (Right to Buy) $66.66 A 115000 Acquired 2031-11-07 Common Stock (115000) Direct

Footnotes

F1: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 28, 2021.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.51 to $65.47, inclusive.

F3: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2), (4), (5), (6), (8), (9), (10) and (11).

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.59 to $66.55, inclusive.

F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.60 to $67.51, inclusive.

F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.79 to $68.32, inclusive.

F7: Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. One-fourth (1/4th) of the RSUs will vest on November 8, 2022 and the remainder of the shares will vest in equal quarterly installments thereafter through November 8, 2025, subject to the Reporting Person continuing to provide service through each such date.

F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.11 to $65.04, inclusive.

F9: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.13 to $66.12, inclusive.

F10: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.15 to $67.12, inclusive.

F11: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.16 to $67.17, inclusive.

F12: One-fourth (1/4th) of the shares subject to the option will vest November 8, 2022 and the remainder of the shares will vest in equal quarterly installments thereafter through November 8, 2025, subject to the Reporting Person continuing to provide service through each such date.